Paper29891789
Design, Synthesis, Cytotoxic Evaluation and Molecular Docking of New Fluoroquinazolinones as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.
Zayed MF and 5 others. Int J Mol Sci, 2018. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Design, Synthesis, Cytotoxic Evaluation and Molecular Docking of New Fluoroquinazolinones as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects. Papers, record 29891789. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29891789
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Design, Synthesis, Cytotoxic Evaluation and Molecular Docking of New Fluoroquinazolinones as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| ErbB Receptors | Major topic |
| Molecular Docking Simulation | Major topic |
| Polymerization | Major topic |
| Quinazolinones | Major topic |
| Tubulin | Major topic |
| Binding Sites | |
| Cell Death | |
| Cell Line, Tumor | |
| Colchicine | |
| Erlotinib Hydrochloride | |
| Humans | |
| Inhibitory Concentration 50 |
Source PubMed
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25174978 | Synthesis and antihypertensive activity of novel quinazolin-4(3H)-one derivatives. | Cent Nerv Syst Agents Med Chem | 2014 | https://conductscience.org/library/papers/25174978 | PubMed |
| 2 | 10592235 | The Protein Data Bank. | Nucleic Acids Res | 2000 | https://conductscience.org/library/papers/10592235 | PubMed |
| 3 | 18950904 | Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs. | Eur J Med Chem | 2009 | https://conductscience.org/library/papers/18950904 | PubMed |
| 4 | 29227917 | Design, synthesis, molecular docking of new lipophilic acetamide derivatives affording potential anticancer and antimicrobial agents. | Bioorg Chem | 2018 | https://conductscience.org/library/papers/29227917 | PubMed |
| 5 | 19664865 | Synthesis, characterization and derivatization of some novel types of mono- and bis-imidazolidineiminothiones and imidazolidineiminodithiones with antitumor, antiviral, antibacterial and antifungal activities--part I. | Eur J Med Chem | 2009 | https://conductscience.org/library/papers/19664865 | PubMed |
| 6 | 16971132 | Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs. | Bioorg Med Chem | 2006 | https://conductscience.org/library/papers/16971132 | PubMed |
| 7 | 24648828 | Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents. | Saudi Pharm J | 2014 | https://conductscience.org/library/papers/24648828 | PubMed |
| 8 | 16366606 | New potential anticancer agents based on the anthranilic acid scaffold: synthesis and evaluation of biological activity. | J Med Chem | 2005 | https://conductscience.org/library/papers/16366606 | PubMed |
| 9 | 23487401 | Design, synthesis and biological evaluation studies of novel quinazoline derivatives as cytotoxic agents. | Drug Res (Stuttg) | 2013 | https://conductscience.org/library/papers/23487401 | PubMed |
| 10 | 15072839 | Synthesis, cytotoxicity, and inhibitory effects on tubulin polymerization of a new 3-heterocyclo substituted 2-styrylquinazolinones. | Eur J Med Chem | 2004 | https://conductscience.org/library/papers/15072839 | PubMed |
| 11 | 29317147 | Fusarithioamide B, a new benzamide derivative from the endophytic fungus Fusarium chlamydosporium with potent cytotoxic and antimicrobial activities. | Bioorg Med Chem | 2018 | https://conductscience.org/library/papers/29317147 | PubMed |
| 12 | 28215601 | Design and synthesis of quinazoline-3,4-(4H)-diamine endowed with thiazoline moiety as new class for DPP-4 and DPPH inhibitor. | Bioorg Chem | 2017 | https://conductscience.org/library/papers/28215601 | PubMed |
| 13 | 29385728 | The Design and Development of Potent Small Molecules as Anticancer Agents Targeting EGFR TK and Tubulin Polymerization. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29385728 | PubMed |
| 14 | 12735990 | Synthesis and antihyperglycemic activity of suitably functionalized 3H-quinazolin-4-ones. | Bioorg Med Chem | 2003 | https://conductscience.org/library/papers/12735990 | PubMed |
| 15 | 22551678 | New quinazolinone-pyrimidine hybrids: synthesis, anti-inflammatory, and ulcerogenicity studies. | Eur J Med Chem | 2012 | https://conductscience.org/library/papers/22551678 | PubMed |
| 16 | 20724039 | Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones. | Eur J Med Chem | 2010 | https://conductscience.org/library/papers/20724039 | PubMed |
| 17 | 20510483 | Synthesis of some new 4(3H)-quinazolinone-2-carboxaldehyde thiosemicarbazones and their metal complexes and a study on their anticonvulsant, analgesic, cytotoxic and antimicrobial activities - part-1. | Eur J Med Chem | 2010 | https://conductscience.org/library/papers/20510483 | PubMed |
| 18 | 29280968 | Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects. | Molecules | 2017 | https://conductscience.org/library/papers/29280968 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42136942 | Discovery of novel quinazoline-sulfonamide derivatives with promising antidiabetic activity. | Front Chem | 2026 | https://conductscience.org/library/papers/42136942 | PubMed |
| 41599658 | Design, Synthesis, and Biological Evaluation of N-Acyl-Hydrazone-Linked Quinazolinone Derivatives with Antioxidant, Antimicrobial, and Anticancer Potential. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41599658 | PubMed |
| 41379296 | Pharmacological effect of quinazoline-2,4(1H,3H)-dione derivatives: a review. | Mol Divers | 2026 | https://conductscience.org/library/papers/41379296 | PubMed |
| 41053651 | Novel anticancer effect of substituted imidazole derivatives against urothelial carcinoma: integrating In vitro screening and molecular docking for target kinases. | BMC Cancer | 2025 | https://conductscience.org/library/papers/41053651 | PubMed |
| 40106127 | Spiroindoline quinazolinedione derivatives as inhibitors of P-glycoprotein: potential agents for overcoming multidrug resistance in cancer therapy. | Mol Divers | 2025 | https://conductscience.org/library/papers/40106127 | PubMed |
| 38965630 | 6-Bromo quinazoline derivatives as cytotoxic agents: design, synthesis, molecular docking and MD simulation. | BMC Chem | 2024 | https://conductscience.org/library/papers/38965630 | PubMed |
| 38899242 | Quinazoline Derivatives as Targeted Chemotherapeutic Agents. | Cureus | 2024 | https://conductscience.org/library/papers/38899242 | PubMed |
| 37569792 | Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide Analogs. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37569792 | PubMed |
| 35631362 | A Mini Review on Isatin, an Anticancer Scaffold with Potential Activities against Neglected Tropical Diseases (NTDs). | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/35631362 | PubMed |
| 34832895 | New Multi-Targeted Antiproliferative Agents: Design and Synthesis of IC261-Based Oxindoles as Potential Tubulin, CK1 and EGFR Inhibitors. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/34832895 | PubMed |
| 30746734 | Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy. | Med Res Rev | 2019 | https://conductscience.org/library/papers/30746734 | PubMed |
| 30002297 | Quinazolinone-Amino Acid Hybrids as Dual Inhibitors of EGFR Kinase and Tubulin Polymerization. | Molecules | 2018 | https://conductscience.org/library/papers/30002297 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKR1B1 | 231 | PubTator's text mining | https://conductscience.org/library/genes/231 | NCBI Gene |
| DHFR | 1719 | PubTator's text mining | https://conductscience.org/library/genes/1719 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| SRC | 6714 | PubTator's text mining | https://conductscience.org/library/genes/6714 | NCBI Gene |
| TXK | 7294 | PubTator's text mining | https://conductscience.org/library/genes/7294 | NCBI Gene |
| TYMS | 7298 | PubTator's text mining | https://conductscience.org/library/genes/7298 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29891789
GET https://conductscience.org/api/papers/v1/29891789/authors